Long COVID

Long COVID
source
Name	Long COVID
Synonyms	Post-COVID-19 condition, post-acute sequelae of SARS-CoV-2 infection (PASC), chronic COVID syndrome
Field	Infectious diseases, Pulmonology, Neurology, Cardiology
Symptoms	Fatigue, cognitive dysfunction, shortness of breath, chest pain
Complications	Postural orthostatic tachycardia syndrome, Myalgic encephalomyelitis/chronic fatigue syndrome, organ damage
Onset	Following acute COVID-19
Duration	Weeks to years
Causes	SARS-CoV-2 infection
Risks	Severe initial infection, Type 2 diabetes, Autoimmunity
Diagnosis	Based on symptom history after COVID-19
Differential	Other post-viral syndromes, Autoimmune disease
Prevention	COVID-19 vaccine, Infection control
Treatment	Symptom management, rehabilitation
Medication	Off-label use of various pharmaceuticals
Prognosis	Variable; many improve over time
Frequency	Estimated 10-30% of COVID-19 cases

Long COVID. It is a complex, multisystem condition characterized by a constellation of symptoms that persist or develop after the acute phase of a SARS-CoV-2 infection. The condition, formally termed post-acute sequelae of SARS-CoV-2 infection (PASC) by the National Institutes of Health, represents a significant and ongoing public health challenge following the COVID-19 pandemic. Recognition and research into the syndrome have been advanced by patient-led advocacy groups and major health bodies like the World Health Organization.

Definition and classification

The World Health Organization published a clinical case definition, describing it as a condition occurring in individuals with a history of probable or confirmed SARS-CoV-2 infection, with symptoms lasting at least two months that cannot be explained by an alternative diagnosis. The National Institutes of Health, through its RECOVER Initiative, uses the term PASC and emphasizes a research-focused framework. Classifications often distinguish between sub-syndromes such as post-intensive care syndrome, persistent viral-induced symptoms, and new-onset Autoimmune disease or conditions like Postural orthostatic tachycardia syndrome. This heterogeneity makes a single, simple classification challenging.

Signs and symptoms

The clinical presentation is highly variable, encompassing over 200 reported symptoms across multiple organ systems. Common and debilitating symptoms include profound fatigue, post-exertional malaise, and cognitive dysfunction often referred to as "brain fog". Respiratory complaints like shortness of breath and cough are frequent, as are cardiovascular issues such as chest pain and palpitations, sometimes linked to Postural orthostatic tachycardia syndrome. Neurological manifestations can include Headache, Sleep disorder, Anosmia, and Dysgeusia. Many patients also report musculoskeletal pain, gastrointestinal disturbances, and a recurrence of symptoms following physical or mental exertion.

Causes and risk factors

The precise pathophysiology is an area of intense research and is likely multifactorial. Leading hypotheses include persistent viral reservoirs of SARS-CoV-2, immune dysregulation leading to Autoimmunity, reactivation of latent viruses like Epstein–Barr virus, widespread endothelial damage and microclot formation, and dysautonomia. Identified risk factors for developing the condition include the severity of the initial COVID-19 infection, particularly hospitalization or Intensive care unit admission. Pre-existing conditions such as Type 2 diabetes, Asthma, and higher Body mass index also appear to increase risk, while vaccination with a COVID-19 vaccine is associated with a reduced incidence.

Diagnosis and assessment

There is no single diagnostic test; diagnosis is primarily clinical, based on a history of COVID-19 and the exclusion of other potential causes for the symptoms. Assessment is typically comprehensive and multidisciplinary, given the systemic nature of the illness. Clinicians may utilize a battery of tests including Pulmonary function testing, Echocardiography, Magnetic resonance imaging of the brain or other organs, and autonomic testing for conditions like Postural orthostatic tachycardia syndrome. Biomarker research is ongoing within programs like the RECOVER Initiative to identify objective diagnostic tools.

Management and treatment

Management is currently supportive and focuses on alleviating specific symptoms, as no universal curative treatment exists. A cornerstone of care is pacing and energy management to avoid post-exertional symptom exacerbation. Rehabilitation, including Physical therapy and Occupational therapy, is often tailored and gradual. Pharmacological approaches are symptom-specific and may include off-label use of medications for fatigue, cognitive dysfunction, or cardiovascular symptoms. Many patients are referred to specialized post-COVID clinics that coordinate care across specialties like Pulmonology, Cardiology, and Neurology.

Epidemiology and prognosis

Estimates of prevalence vary, but a significant proportion of individuals who contract SARS-CoV-2 experience persistent symptoms; meta-analyses suggest a global burden affecting tens of millions. The condition has been documented following infection with various SARS-CoV-2 variants, including Omicron. Prognosis is variable; many patients experience slow improvement over months or years, while a subset report persistent, debilitating symptoms that significantly impact quality of life and ability to work. The long-term socioeconomic impact, including effects on the workforce, is a major concern for governments and health systems worldwide.

Category:COVID-19 Category:Post-viral syndromes Category:Chronic diseases